HEPION PHARMACEUTICALS, INC. Proceeds from Issuance of Private Placement
HEPION PHARMACEUTICALS, INC. (HEPA) reported Proceeds from Issuance of Private Placement of $3.23 million for the 12-month period ending 2014-06-30, per its 10-K filed 2015-09-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2015-09-25
- HEPION PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2014-06-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2014 was $3.23M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 11 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $3.23M 10-K · filed 2015-09-25 | ||
| 2014-03-31 | $3.23M 10-Q · filed 2015-05-14 | $3.23M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |